Details for Patent: 11,969,471
Which drugs does patent 11,969,471 protect, and when does it expire?
Patent 11,969,471 protects MYCAPSSA and is included in one NDA.
This patent has fifty-six patent family members in twenty-five countries.
Summary for Patent: 11,969,471
| Title: | Pharmaceutical compositions and related methods of delivery |
| Abstract: | The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. |
| Inventor(s): | Roni Mamluk, Moshe Tzabari, Karen Marom, Paul Salama, Irina Weinstein |
| Assignee: | Amryt Pharmaceuticals Inc |
| Application Number: | US17/879,430 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 11,969,471
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiesi | MYCAPSSA | octreotide acetate | CAPSULE, DELAYED RELEASE;ORAL | 208232-001 | Jun 26, 2020 | RX | Yes | Yes | 11,969,471 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,969,471
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009294320 | ⤷ Start Trial | |||
| Brazil | PI0918652 | ⤷ Start Trial | |||
| Canada | 2737456 | ⤷ Start Trial | |||
| Canada | 2963659 | ⤷ Start Trial | |||
| Canada | 3080587 | ⤷ Start Trial | |||
| China | 102176900 | ⤷ Start Trial | |||
| China | 106974888 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
